• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, INC.(CRM-SYLMAR) ELLIPSE VR; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, INC.(CRM-SYLMAR) ELLIPSE VR; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number CD1411-36Q
Device Problems Pacing Problem (1439); Failure to Sense (1559); Defective Device (2588); Appropriate Term/Code Not Available (3191)
Patient Problems No Consequences Or Impact To Patient (2199); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/29/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).The results/methods and conclusion codes along with investigation results will be provided in the final report.
 
Event Description
It was reported that the patient presented in clinic for a follow up.Upon examination, it was discovered that the right ventricular lead was losing sensing when the patient raised her arm 90 degrees.On (b)(6) 2020, the patient was brought to the hospital for a lead revision procedure.While prepping the surgical site, it was noted that the loss of sensing which precipitated ventricular pacing occurred while the hospital staff was pressing on the implantable cardioverter defibrillator.The incision was opened and the device was removed.A tug test was performed to demonstrate the setscrew was securely tightened at the initial implant.A photograph was obtained showing the pin correctly inserted into the device header.The physician manipulated the header and loss of sensing and loss of ventricular pacing were observed.The right ventricular lead was disconnected from the device and threshold values were checked on a pacing system analyzer (psa).All thresholds were appropriate.The physician then manipulated the exposed portion of the lead but no loss of sensing was observed on the psa.The physician concluded that the issue was the header of the device.A new device was implanted and tested.No loss of sensing was noted on the new device.The pocket was then closed and the patient was discharged home after the procedure.
 
Manufacturer Narrative
The reported header anomaly, failure to sense, and pacing problems were not confirmed in the laboratory.The device was tested on the bench, and no anomalies were found.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELLIPSE VR
Type of Device
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
ST. JUDE MEDICAL, INC.(CRM-SYLMAR)
15900 valley view court
sylmar CA 91342
MDR Report Key11178720
MDR Text Key227074709
Report Number2017865-2021-02197
Device Sequence Number1
Product Code NVZ
UDI-Device Identifier05414734507738
UDI-Public05414734507738
Combination Product (y/n)N
PMA/PMN Number
P910023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 03/26/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2021
Device Model NumberCD1411-36Q
Device Catalogue NumberCD1411-36Q
Device Lot NumberA000088108
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/04/2021
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 12/29/2020
Initial Date FDA Received01/15/2021
Supplement Dates Manufacturer Received03/09/2021
Supplement Dates FDA Received03/27/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age30 YR
-
-